What is Global Surgical Anti-Adhesion Products Market?
The Global Surgical Anti-Adhesion Products Market is a specialized and in-depth study of the healthcare industry, with a particular focus on the global market trend analysis. The Surgical Anti-Adhesion Products are medical devices that are used to minimize the incidence of post-surgical adhesions. These adhesions are bands of scar tissue that can form after a surgery, causing organs and tissues to stick together. This can lead to complications such as chronic pain, bowel obstruction, and infertility. The market for these products is driven by the increasing number of surgeries worldwide, advancements in technology, and growing awareness about the complications associated with post-surgical adhesions. However, the high cost of these products and stringent regulatory policies may hinder the market growth. The market is segmented based on product type, application, and region. The product types include films and gels, with gels being the most popular due to their ease of application and effectiveness. The applications of these products are mainly in general/abdominal surgery, pelvic/gynecological surgery, and other surgeries. The market is further divided into North America, Europe, Asia-Pacific, and Rest of the World, with North America holding the largest market share due to the high prevalence of surgeries and advanced healthcare infrastructure.
Films, Gels in the Global Surgical Anti-Adhesion Products Market:
The Global Surgical Anti-Adhesion Products Market is segmented into two main types: films and gels. Films are thin layers of anti-adhesion material that are placed over the surgical site to prevent the formation of adhesions. They are typically made of synthetic materials such as polyethylene glycol (PEG) and carboxymethylcellulose (CMC). On the other hand, gels are liquid or semi-liquid substances that are applied to the surgical site. They form a barrier that prevents the tissues from sticking together. Gels are often preferred over films due to their ease of application and ability to conform to the surgical site. They are also more effective in preventing adhesions as they can cover a larger area and penetrate deeper into the tissues. The market for gels is larger than that for films, accounting for about 65% of the total market. This is due to the higher demand for gels in various surgical procedures, including general/abdominal surgery, pelvic/gynecological surgery, and other surgeries. The market for films is also significant, but it is smaller compared to gels due to their higher cost and more complex application process.
General/abdominal Surgery, Pelvic/gynecological Surgery, Other Surgery in the Global Surgical Anti-Adhesion Products Market:
The Global Surgical Anti-Adhesion Products Market finds its applications in various surgical procedures, including general/abdominal surgery, pelvic/gynecological surgery, and other surgeries. General/abdominal surgery is the largest application segment, accounting for about 50% of the total market. This is due to the high incidence of adhesions in abdominal surgeries, which can lead to complications such as bowel obstruction and chronic pain. Anti-adhesion products are used in these surgeries to minimize the risk of adhesions and improve patient outcomes. Pelvic/gynecological surgery is another major application segment. Adhesions are a common complication in gynecological surgeries, leading to conditions such as pelvic pain and infertility. Anti-adhesion products are used in these surgeries to prevent the formation of adhesions and reduce the risk of these complications. Other surgeries where these products are used include orthopedic surgeries, cardiovascular surgeries, and neurosurgeries. The use of anti-adhesion products in these surgeries is expected to increase in the future due to the growing awareness about the benefits of these products and advancements in technology.
Global Surgical Anti-Adhesion Products Market Outlook:
The Global Surgical Anti-Adhesion Products Market was valued at US$ 459 million in 2022. It is projected to reach a value of US$ 524.5 million by 2029, growing at a Compound Annual Growth Rate (CAGR) of 1.9% during the forecast period of 2023-2029. This growth can be attributed to the increasing number of surgeries worldwide, advancements in technology, and growing awareness about the complications associated with post-surgical adhesions. The market is dominated by the top 3 players, who collectively hold about 20% of the global market share. The majority of the market is made up of gels, which account for about 65% of the total market. This is due to their ease of application and effectiveness in preventing adhesions. The largest application segment is general/abdominal surgery, which holds about 50% of the market share. This is due to the high incidence of adhesions in abdominal surgeries and the effectiveness of anti-adhesion products in minimizing these complications.
| Report Metric | Details |
| Report Name | Surgical Anti-Adhesion Products Market |
| Accounted market size in 2023 | US$ 459 million |
| Forecasted market size in 2030 | US$ 524.5 million |
| CAGR | 1.9% |
| Base Year | 2023 |
| Forecasted years | 2024 - 2030 |
| Segment by Type |
|
| Segment by Application |
|
| Consumption by Region |
|
| By Company | Ethicon, SANOFI, Baxter International, Pathfinder Cell Therapy, Covidien, Integra Life Sciences, FzioMed, Anika Therapeutics, Bioscompass, Shanghai Haohai, SJZ Yishengtang, Singclean Medical, SJZ Ruinuo, HK Wellife |
| Forecast units | USD million in value |
| Report coverage | Revenue and volume forecast, company share, competitive landscape, growth factors and trends |
